AHK (Tripeptide-3)
CosmeticCosmetic skincare peptide · also known as Ahk
Last updated 29 October 2026
AHK (Tripeptide-3) is a small peptide used in topical skincare and hair products, marketed to support hair and skin. Used with no medicinal claims, it is regulated as a cosmetic ingredient. The evidence is modest.
Key points
- AHK (Tripeptide-3) is a three amino acid peptide added to skincare and scalp products.
- It is marketed to support hair growth and the condition of the skin.
- On the skin, with no medicinal claims, it is regulated as a cosmetic ingredient in the UK.
- The evidence is modest, and cosmetic claims are best kept in proportion.
Quick facts
- What it is
- Cosmetic skincare peptide (Tripeptide-3)
- Marketed for
- Hair and skin condition
- UK status
- Legal as a cosmetic ingredient (no medicinal claims)
- Evidence
- Modest
How it works
Small peptides like this are used in cosmetics to signal to skin and hair follicle cells, with the aim of supporting their natural processes. Most of the supporting evidence is from laboratory and manufacturer studies.
What the evidence shows
There are studies, often from manufacturers, suggesting modest cosmetic effects. Independent, high quality trials are limited, so claims should be kept modest.
What it does not settle
- Independent high quality evidence is limited.
- Effects are usually modest and build slowly.
- Results depend on the product and how it is used.
Side effects
Common
- Usually well tolerated, though some people get mild irritation or redness. A patch test is sensible.
Report any suspected side effect through the MHRA Yellow Card scheme.
UK legal status and access
As a topical cosmetic ingredient with no medicinal claims, AHK (Tripeptide-3) is legal and widely sold in skincare and hair products. Any version sold with medicinal claims, or for injection, would fall under medicines rules.
Common questions
Is it legal in the UK?
Yes, as a cosmetic ingredient used with no medicinal claims.
Does it work?
It is marketed for hair and skin, but independent evidence is limited and any effect is modest.
Factual reference only, not medical advice. We give no dosing for unlicensed compounds.